Jane Street
GH icon

Jane Street’s Guardant Health GH Stock Holding History

Jane Street’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.33M Sell
101,000
-237,900
-70% -$23.9M ﹤0.01% 2626
2025
Q4 		$34.6M Sell
338,900
-116,400
-26% -$10.4M 0.01% 1151
2025
Q3 		$28.4M Buy
455,300
+116,700
+34% +$6.35M ﹤0.01% 1342
2025
Q2 		$17.6M Buy
338,600
+26,500
+8% +$1.18M ﹤0.01% 1574
2025
Q1 		$13.3M Buy
312,100
+262,200
+525% +$11.3M ﹤0.01% 1666
2024
Q4 		$1.52M Sell
49,900
-188,700
-79% -$5.31M ﹤0.01% 4604
2024
Q3 		$5.47M Buy
238,600
+155,200
+186% +$4.39M ﹤0.01% 2717
2024
Q2 		$2.41M Buy
83,400
+62,800
+305% +$1.46M ﹤0.01% 4175
2024
Q1 		$425K Sell
20,600
-112,200
-84% -$2.41M ﹤0.01% 6966
2023
Q4 		$3.59M Sell
132,800
-45,400
-25% -$1.19M ﹤0.01% 3344
2023
Q3 		$5.28M Buy
178,200
+53,800
+43% +$1.89M ﹤0.01% 2537
2023
Q2 		$4.45M Sell
124,400
-45,400
-27% -$1.3M ﹤0.01% 2916
2023
Q1 		$3.98M Sell
169,800
-63,600
-27% -$1.82M ﹤0.01% 2759
2022
Q4 		$6.35M Buy
233,400
+85,300
+58% +$3.9M ﹤0.01% 2171
2022
Q3 		$7.97M Sell
148,100
-169,600
-53% -$8.71M ﹤0.01% 1959
2022
Q2 		$12.8M Buy
317,700
+179,700
+130% +$8.9M 0.01% 1483
2022
Q1 		$9.14M Buy
138,000
+18,200
+15% +$1.25M ﹤0.01% 2112
2021
Q4 		$12M Buy
119,800
+5,500
+5% +$569K ﹤0.01% 1678
2021
Q3 		$14.3M Buy
114,300
+19,200
+20% +$2.28M 0.01% 1402
2021
Q2 		$11.8M Buy
95,100
+57,100
+150% +$7.68M ﹤0.01% 1537
2021
Q1 		$5.8M Sell
38,000
-12,700
-25% -$1.92M ﹤0.01% 2195
2020
Q4 		$6.53M Sell
50,700
-13,300
-21% -$1.53M ﹤0.01% 1808
2020
Q3 		$7.15M Buy
64,000
+30,100
+89% +$2.75M ﹤0.01% 1500
2020
Q2 		$2.75M Sell
33,900
-19,600
-37% -$1.58M ﹤0.01% 2626
2020
Q1 		$3.72M Buy
53,500
+10,000
+23% +$767K ﹤0.01% 1416
2019
Q4 		$3.4M Buy
43,500
+20,700
+91% +$1.49M ﹤0.01% 1403
2019
Q3 		$1.46M Buy
+22,800
New +$2.01M ﹤0.01% 2150

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's GH Position: Q1 2026 in Review

Jane Street reduced its Guardant Health (GH) stake by 99% in Q1 2026, selling an estimated $51.1M and leaving 4,803 shares worth $444K. The position accounts for ﹤0.01% of the portfolio, ranked #8344.

Jane Street first reported a position in GH in Q2 2019 and has held it in 27 quarters since. The position peaked at $52.5M in Q4 2025. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Jane Street held 4,803 shares of Guardant Health worth $444K as of Q1 2026.
  • Jane Street sold 508,817 Guardant Health shares in Q1 2026, an estimated $51.1M.
  • Guardant Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8344 holding.
  • Jane Street first reported a position in Guardant Health in Q2 2019 and has held it in 27 quarters since.
  • Jane Street's Guardant Health position peaked at $52.5M in Q4 2025.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.